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Purpose
One-third or more US adults, and similar numbers else-
where, use complementary and integrative medicine
(CIM). The results of previous systematic reviews of the
economic impacts of CIM are limited and now out of
date. The purpose of this comprehensive review is to
capture and highlight for policy makers what is cur-
rently known about the economics of CIM, and to make
recommendations for future research.
Methods
PubMed, CINAHL, AMED, PsychInfo, Web of Science,
and EMBASE were searched through December 2010
using a comprehensive search strategy. In addition, bib-
liographies were searched, and key researchers con-
tacted. All full economic evaluations published 2001-
2010 were also subjected to five study quality criteria
and one indicator of whether the study’sr e s u l t sw e r e
transferable (i.e., could be adjusted to apply/generalize
to other settings).
Results
A total of 340 economic evaluations of CIM were found,
of which 206, covering a wide variety of CIM for differ-
ent populations, were published 2001-2010, and 134 of
those were full economic evaluations. Despite the fact
that most CIM users utilize more than one type of CIM,
almost all (88%) of these studies were of single CIM
therapies and only one evaluated coordinated care
across CIM and conventional practitioners. Of the
recent full evaluations 32 (24%) met all five study quality
criteria, and 17 of these also met the minimum criterion
for study transferability.
Conclusion
This comprehensive review identified a substantial num-
ber of economic evaluations of CIM and emerging evi-
dence of cost-effectiveness in at least a few clinical
populations. Therefore, instead of more studies, what is
actually needed are higher quality studies—both in
terms of enhanced study quality (to increase the validity
of the results for its targeted population and setting)
and better transferability (to increase the usefulness of
results to other decision-makers in other settings). To
this end, eight specific recommendations are made.
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